Warning
New Life Pharma LLC Recalls Semaglutide Inj
This is a Class II recall. This product may cause temporary health problems or pose a slight threat of a serious nature.
Source: FDA
WarningRecall #D-0393-2026Drug / Pharmaceutical
New Life Pharma LLC Recalls Semaglutide Inj
New Life Pharma LLC · Class II — Moderate Risk
Product Description
Semaglutide Inj., 2 mg x 5, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-001-06
Reason for Recall
Lack of Assurance of Sterility
FDA Classification
Class II — Moderate Risk
A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Distribution
OH
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
The FDA classified this recall as Class II, indicating the pharmaceutical product may cause temporary health problems or poses a slight threat of a serious nature. New Life Pharma LLC initiated the recall on February 26, 2026 affecting 2 vials. Lack of Assurance of Sterility. The product was distributed in OH. Consumers should check their purchases and discontinue use of any affected product. Contact New Life Pharma LLC for further instructions.
Sources: FDA openFDA Enforcement Database
This recall appears in: Drug & Medication Defects.